Arax Advisory Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $605K | Sell |
2,766
-23
| -0.8% | -$5.03K | 0.03% | 351 |
|
|
2025
Q1 | $624K | Sell |
2,789
-576
| -17% | -$129K | 0.04% | 258 |
|
|
2024
Q4 | $1.1M | Sell |
3,365
-120
| -3% | -$39.3K | 0.07% | 166 |
|
|
2024
Q3 | $1.05M | Buy |
3,485
+1,132
| +48% | +$340K | 0.09% | 116 |
|
|
2024
Q2 | $775K | Buy |
2,353
+238
| +11% | +$78.4K | 0.08% | 134 |
|
|
2024
Q1 | $837K | Buy |
2,115
+832
| +65% | +$329K | 0.09% | 116 |
|
|
2023
Q4 | $452K | Buy |
1,283
+64
| +5% | +$22.5K | 0.05% | 169 |
|
|
2023
Q3 | $458K | Buy |
1,219
+786
| +182% | +$295K | 0.06% | 150 |
|
|
2023
Q2 | $166K | Hold |
433
| – | – | 0.02% | 270 |
|
|
2023
Q1 | $150K | Buy |
433
+12
| +3% | +$4.16K | 0.02% | 280 |
|
|
2022
Q4 | $99.1K | Buy |
+421
| New | +$99.1K | 0.01% | 334 |
|
|
2022
Q3 | – | Sell |
-12
| Closed | -$4K | – | 1270 |
|
|
2022
Q2 | $4K | Sell |
12
-9
| -43% | -$3K | ﹤0.01% | 861 |
|
|
2022
Q1 | $9K | Hold |
21
| – | – | ﹤0.01% | 676 |
|
|
2021
Q4 | $10K | Hold |
21
| – | – | ﹤0.01% | 669 |
|
|
2021
Q3 | $9K | Sell |
21
-32
| -60% | -$13.7K | ﹤0.01% | 669 |
|
|
2021
Q2 | $19K | Buy |
+53
| New | +$19K | ﹤0.01% | 589 |
|